GeneDx Holdings Corp (NAS:WGS)
$ 63.03 +0.43 (+0.69%) Market Cap: 1.87 Bil Enterprise Value: 1.87 Bil PE Ratio: 0 PB Ratio: 7.36 GF Score: 63/100

Q1 2026 GeneDx Holdings Corp Earnings Call Transcript

May 04, 2026 / 08:30PM GMT
Release Date Price: $67.93 (+3.90%)
Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the GeneDx first-quarter 2026 earnings conference call. (Operator Instructions) Please be reminded that this conference call is being recorded.

At this time, I'd like to introduce your host for today's presentation, Ms. Sabrina Dunbar of Investor Relations. Ma'am, please begin.

Sabrina Dunbar
GeneDx Holdings Corp - Director of Investor Relations and Communications

Thank you, operator, and thank you to everyone for joining us today. On the call, we have Katherine Stueland, President and Chief Executive Officer; and Kevin Feeley, Chief Financial Officer. Earlier today, GeneDx released financial results for the first quarter ended March 31, 2026.

Before we begin, please take note of our cautionary statement. We may make forward-looking statements on today's call, including about our business plans, guidance, and outlook. Forward-looking statements inherently involve risks and uncertainties and only reflect our view as of today, May 4, and we're under no obligation to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot